PCM
RMD icon

Prelude Capital Management’s ResMed RMD Stock Holding History

Prelude Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,500
Closed -$589K – 1735
2016
Q4 		$589K Buy
9,500
+1,800
+23% +$110K 0.07% 294
2016
Q3 		$499K Buy
+7,700
New +$513K 0.05% 315

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prelude Capital Management's RMD Position: Q1 2026 in Review

Prelude Capital Management opened a new position in ResMed (RMD) in Q1 2026: 1,095 shares worth $246K. The stake represents 0.02% of the portfolio and ranks #808 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in RMD as recently as Q1 2025.

Prelude Capital Management first reported a position in RMD in Q3 2013 and has held it in 16 quarters since. The position peaked at $702K in Q1 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Prelude Capital Management held 1,095 shares of ResMed worth $246K as of Q1 2026.
  • ResMed was a new Prelude Capital Management position in Q1 2026.
  • ResMed made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #808 holding.
  • Prelude Capital Management first reported a position in ResMed in Q3 2013 and has held it in 16 quarters since.
  • Prelude Capital Management's ResMed position peaked at $702K in Q1 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.